grant

Epigenetic modification of HIV-1 Cap

Organization UNIVERSITY OF MINNESOTALocation MINNEAPOLIS, UNITED STATESPosted 14 Aug 2024Deadline 30 Jun 2029
NIHUS FederalResearch GrantFY20255' Capped RNA5' mRNA Cap StructureAIDS VirusAchievementAchievement AttainmentAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAnti-Retroviral AgentsAnti-viral TherapyBasic ResearchBasic ScienceBindingBlood PlasmaCell BodyCellsCellular StressCellular Stress ResponseChronicClampingsClinicalClosure by clampCommunicationComplexCoupledCryo-electron MicroscopyCryoelectron MicroscopyDataDetectionDevelopmentDocumentationDrug resistanceDrugsElectron CryomicroscopyEnvironmentEnzyme GeneEnzymesEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEquilibriumEvolutionFK506 Binding Protein 12-Rapamycin Associated Protein 1FKBP12 Rapamycin Complex Associated Protein 1FRAP1FRAP1 geneFRAP2FoundationsFutureGene ExpressionGenerationsGoalsGuanosineHIVHIV Viral Protein RHIV vpr Gene ProductHIV-1HIV-1 vpr Gene ProductsHIV-IHIV1HomodimerizationHuman Immunodeficiency Virus Type 1Human Immunodeficiency VirusesHuman immunodeficiency virus 1HypermethylationImmuneImmune Cell ActivationImmune signalingImmunesImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsInnate Immune ResponseIntervening SequencesIntronsKnowledgeLAV-HTLV-IIILicensingLinkLong-term infectionLymphadenopathy-Associated VirusMechanistic Target of RapamycinMediatingMedicationMessenger RNAMethylationModelingModificationMolecularMolecular ImmunologyMolecular InteractionMolecular Modeling Nucleic Acid BiochemistryMolecular Modeling Protein/Amino Acid BiochemistryMolecular ModelsMolecular ProbesMolecular VirologyMyeloid CellsNIAIDNational Institute of Allergy and Infectious DiseaseNon-Polyadenylated RNANuclearOutcomePathway interactionsPatientsPharmaceutical PreparationsPlasmaPlasma SerumPost-Transcriptional ControlPost-Transcriptional RNA ModificationPost-Transcriptional RNA ProcessingPost-Transcriptional RegulationPrecipitationPredispositionProcessProductionPropertyProteinsPublic HealthPublishingR Gene ProductsRAFT1RHA enzymeRNARNA CapsRNA Gene ProductsRNA helicase ARegulationReportingResearchReticuloendothelial System, Serum, PlasmaRibonucleic AcidRibonucleoproteinsRoleScientistShapesStructureSusceptibilityT-CellsT-LymphocyteTherapeuticTranscriptTranslationsValidationViralViral BurdenViral Gene ProductsViral Gene ProteinsViral GenesViral LoadViral Load resultViral ProteinsViral Regulatory ProteinsVirionVirus ParticleVirus ReplicationVirus-HIVWorkYinanti-retroviralarmbalancebalance functionbiological adaptation to stresscell stresschronic infectioncryo-EMcryoEMcryogenic electron microscopydevelopmentaldrug resistantdrug/agentdruggable targetepigeneticallyexhaustexhaustionexperienceexperimentexperimental researchexperimental studyexperimentsfundamental researchimmune activationinnovateinnovationinnovativeinsightmRNAmTORmammalian target of rapamycinmethyl groupmolecular modelingnovelpathogenic viruspathwaypersistent infectionpost-transcriptional gene regulationprecipitationspreventpreventingrap Gene Productsreaction; crisisrecruitresistance to Drugresistant to Drugrev-Responsive Elementssensorsmall moleculesocial rolestress responsestress; reactionstructural biologythymus derived lymphocytetooltranslationtranslational studyvalidationsviral RNAviral infectious disease treatmentviral multiplicationviral pathogenviral replicationvirologyvirus RNAvirus host interactionvirus multiplicationvirus pathogenvirus proteinvpr Gene Productsvpr Protein
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project summary
Basic research opens the door to better understand, treat, and ultimately prevent existing and

emerging public health threats. NIAID has prioritized fundamental research into underpinnings of

the HIV-associated chronic immune activation despite the control of viral load by daily

antiretroviral medication. Recent findings of the…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Epigenetic modification of HIV-1 Cap — UNIVERSITY OF MINNESOTA | UNITED STATES | Aug 2024 | Dev Procure